A5023422821- Biomedical Ethics and Regulation
- Law, AI, and Intellectual Property
- Risk Perception and Management
- Ethics in Clinical Research
- Intellectual Property and Patents
- Ethics and Social Impacts of AI
- Regulation and Compliance Studies
- Genetically Modified Organisms Research
- Biotechnology and Related Fields
- Neuroethics, Human Enhancement, Biomedical Innovations
- Medical Malpractice and Liability Issues
- Science, Research, and Medicine
- International Environmental Law and Policies
- CRISPR and Genetic Engineering
- Health, Environment, Cognitive Aging
- Health Systems, Economic Evaluations, Quality of Life
- Nanoparticles: synthesis and applications
- Legal Systems and Judicial Processes
- Law, Economics, and Judicial Systems
- Climate Change Communication and Perception
- Digital Transformation in Law
- Pharmaceutical Economics and Policy
- Blockchain Technology Applications and Security
- Innovation Policy and R&D
- Genomics and Rare Diseases
Arizona State University
2014-2024
Columbia University Irving Medical Center
2021
National Society of Genetic Counselors
2020
College of Law
2003-2018
University of Arizona
2011-2016
Tempe Union High School District
2013
University of Louisville Hospital
2009
U.S. National Arboretum
2007
Michigan United
2007
Southwest Florida Research
2007
Comprehensive disease classification and staging is required to address unmet needs of aging populations
Health care is transitioning from genetics to genomics, in which single-gene testing for diagnosis being replaced by multi-gene panels, genome-wide sequencing, and other multi-genic tests disease diagnosis, prediction, prognosis, treatment. This health transition spurring a new set of increased or novel liability risks providers test laboratories. article describes this both medical liability, addresses 11 areas potential risk, offering recommendations legal actors address manage those risks.
Like all technologies, nanotechnology will inevitably present risks, whether they result from unintentional effects of otherwise beneficial applications, or the malevolent misuse technology. Increasingly, risks new and emerging technologies are being regulated at international level, although governments private experts only beginning to consider appropriate responses nanotechnology. In this paper, we explore both potential posed by regulatory frameworks that law may impose. so doing, also...
The precautionary principle, stated most simply, says it is better to be safe than sorry in regulating health and environmental risks. Marchant (Arizona State U. College of Law) Mossman (health physics, Arizona U.) review ten years application the principle courts European Union, finding that has been
Rapidly emerging technologies, such as AI and robotics, present a serious challenge to traditional models of government regulation. These technologies are advancing so quickly that in many sectors, regulation cannot keep up, given the cumbersome procedural bureaucratic procedures safeguards modern legislative rulemaking processes require. Consequently, regulatory systems will predictively fail put place appropriately tailored measures by time new applications fast-moving begin affect...
As governments around the world struggle to govern a multitude of emerging technologies, they often seek harmonize their regulatory approaches. But there are at least 10 different reasons why nations may oversight specific technology, and discerning which these rationales will apply technology is critical for selecting optimal harmonization approach. The traditional approach negotiation formal international treaties, but, as exemplified by challenges cybersecurity, such treaty-based...
Abstract It is often argued that immediate government action regarding nanotechnology needed to ensure public opinion does not mistakenly view as dangerous, restore trust in government, and increase the legitimacy of through increased participation. This article questions whether governments can achieve these goals. As world lurches toward regulation nanotechnology, we should ask Why rush? Can anticipatory action, perceived doing something , fulfill competing hopes “restore trust,”“pave way”...
The question of whether biotechnology regulation should be based on the process or product has long been debated, with different jurisdictions adopting approaches. European Union adopted a process-based approach, Canada product-based and United States implemented hybrid system. With recent proliferation new methods genetic modification, such as gene editing, regulatory systems, which are premised binary system transgenic conventional approaches, will become increasingly obsolete...
Soft law is defined as a program that sets substantive expectations, but not directly enforceable by government. Because soft bound geographic jurisdiction and can be developed, amended, adopted any entity, it will the dominant form of artificial intelligence (AI) governance for foreseeable future. The objective this document to compile analyze global trends on how tool used government, non-profits, private sector manage AI's methods applications.Inspired similar efforts, contains scoping...
As an international policy issue, nanotechnology (NT) presents a unique set of attributes and poses extraordinary regulatory challenges. Given that NT is major funding priority for governments industry groups around the world, it expected to rapidly evolve advance, presenting risks benefits are still largely unknown even unanticipated. While some politicians, social scientists activists call robust oversight, regulators struggle with their lack data knowledge, far more limited than levels...